About Us
The Health Thread
Ethical Health Journalism
Live
🌍Community Power: DRC's Success in Battling Ebola Outbreaks Through Local Engagement🌍Uganda Begins Crucial Countdown to Declare End of Ebola Outbreak🌍Ebola Outbreak in DR Congo: Building Trust Critical for Healthcare Access in Goma🌍CAR Battles Cholera Outbreak Amidst Displacement and Aid Challenges🌍Syria Strengthens Public Health Defenses with Advanced Disease Detective Training, Integrating AI🌍Community Power: DRC's Success in Battling Ebola Outbreaks Through Local Engagement🌍Uganda Begins Crucial Countdown to Declare End of Ebola Outbreak🌍Ebola Outbreak in DR Congo: Building Trust Critical for Healthcare Access in Goma🌍CAR Battles Cholera Outbreak Amidst Displacement and Aid Challenges🌍Syria Strengthens Public Health Defenses with Advanced Disease Detective Training, Integrating AI
Research Watch
•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•Why Your Lungs May Hold the Secret to Your Stress Levels•नेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकट•Frontline Perspectives on Nursing Leadership in Nepal•Protecting the Smallest Lungs from the Hidden Grip of RSV in Kathmandu•The Heavy Burden of Bullying on Student Wellbeing in Nepal•The Emerging Landscape of Thyroid Health in Central Nepal•How a Recent Western Nepal Study is Redefining Anemia Diagnosis•How H. Pylori is Impacting the Health of Karnali’s High-Altitude Communities•Sweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s Youth•How Missing Checklists and Protocols are Costing Lives in Nepal’s ERs•Why Your Lungs May Hold the Secret to Your Stress Levels

AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.

Researchers

Andreas Hartkopf, Ute-Susann Albert, Rupert Bartsch, Ingo Bauerfeind, Maggie Banys-Paluchowski, Vesna Bjelic-Radisic, Jens-Uwe Blohmer, Peter Dall, Eva Maria Fallenberg, Peter A Fasching, Michael Friedrich, Oleg Gluz, Nadia Harbeck, Jörg Heil, Juliane Hörner-Rieber, Jens Huober, Wolfgang Janni, Hans-Heinrich Kreipe, David Krug, Thorsten Kühn, Sherko Kümmel, Sibylle Loibl, Diana Lüftner, Michael Patrick Lux, Nicolai Maass, Marion Tina van Mackelenbergh, Christoph Mundhenke, Tjoung-Won Park-Simon, Mattea Reinisch, Toralf Reimer, Kerstin Rhiem, Achim Rody, Andreas Schneeweiss, Florian Schütz, Hans-Peter Sinn, Christine Solbach, Erich-Franz Solomayer, Elmar Stickeler, Marc Thill, Michael Untch, Isabell Witzel, Achim Wöckel, Rachel Wuerstlein, Nina Ditsch, Tanja Fehm, Volkmar Müller, Marcus Schmidt

Abstract

Biomarkers are integral to modern breast cancer management by providing essential information for prognosis and treatment selection. This review presents the 2026 update of the recommendations of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) on therapy-relevant prognostic and predictive biomarkers. The recommendations are based on a structured evaluation of the most recent and clinically relevant evidence using the AGO grading system to support decision-making in routine clinical practice.
Source: PubMed (PMID: 42497646)View Original on PubMed